Interferon blocks interleukin 1-induced prostaglandin release from human peripheral monocytes

J Immunol. 1987 May 1;138(9):2857-63.

Abstract

We have studied the short-term effects of interleukin 1, lipopolysaccharide, and interferon on prostaglandin release from freshly isolated human peripheral monocytes. When the cells were pretreated for 8 to 9 hr with either E. coli lipopolysaccharide or recombinant interleukin 1 (beta), prostaglandin release increased. Inclusion of recombinant IFN-alpha or IFN-gamma during the pretreatment phase blocked subsequent prostaglandin release. Interferons were effective at concentrations in the range of 1 to 10 antiviral units/ml, and the inhibition was manifested within several hours after exposure to the lymphokine. Similar trends were observed by measuring thromboxane release. These data suggest antagonistic roles for interleukin 1 and interferon in the regulation of eicosanoid release from monocytes.

MeSH terms

  • Complement System Proteins / physiology
  • Dinoprostone
  • Humans
  • Inflammation / physiopathology
  • Interferon Type I / physiology*
  • Interferon-gamma / physiology*
  • Interleukin-1 / antagonists & inhibitors*
  • Lipopolysaccharides / immunology
  • Macrophages / physiology
  • Monocytes / physiology*
  • Prostaglandins / metabolism*
  • Prostaglandins E / metabolism
  • Recombinant Proteins / pharmacology
  • Thromboxane B2 / metabolism

Substances

  • Interferon Type I
  • Interleukin-1
  • Lipopolysaccharides
  • Prostaglandins
  • Prostaglandins E
  • Recombinant Proteins
  • Thromboxane B2
  • Interferon-gamma
  • Complement System Proteins
  • Dinoprostone